Febuxostat (vs. Allopurinol) In Treating the Hyperuricemia of Gout In Diabetic Patients.

被引：0
|
作者：
Becker, Michael A. [1 ]
MacDonald, Patricia A. [2 ]
Hunt, Barbara [2 ]
Jackson, Robert L. [2 ]
机构：
[1] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[2] Takeda Global Res & Dev Ctr Inc, Deerfield, IL USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1022
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [41] The Effectiveness and Safety of Febuxostat for Chronic Kidney Disease Patients with Gout and Hyperuricemia
    Huang, Chien-Huei
    Wang, Ming-Cheng
    Yen, Chi-Tai
    Cheng, Ching-Lan
    Liu, Pheng-Ying Yeh
    Chang, Hui-Jen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 435 - 436
  • [42] Febuxostat vs Allopurinol in Elderly Gout Subjects: Subgroup Analysis of the CONFIRMS Trial.
    Krishnan, E.
    MacDonald, P. A.
    Hunt, B. J.
    Jackson, R. L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 : S56 - S56
  • [43] Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial
    Helget, Lindsay N.
    Davis-Karim, Anne
    O'Dell, James R.
    Mikuls, Ted R.
    Newcomb, Jeff A.
    Androsenko, Maria
    Brophy, Mary T.
    England, Bryant R.
    Ferguson, Ryan
    Pillinger, Michael H.
    Neogi, Tuhina
    Wu, Hongsheng
    Palevsky, Paul M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 84 (05) : 538 - 545
  • [44] Cardiovascular safety associated with febuxostat versus allopurinol among patients with gout: Update with accumulated use of febuxostat
    Shin, Anna
    Choi, Se Rim
    Han, Minji
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 56
  • [45] A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia
    Xu, Shaoyong
    Liu, Xiangyang
    Ming, Jie
    Chen, Shenren
    Wang, Yangang
    Liu, Xiumei
    Liu, Hong
    Peng, Yongde
    Wang, Jianqin
    Lin, Jinying
    Ji, Haiwang
    Liu, Bin
    Lu, Ying
    Liu, Peng
    Zhang, Yonghong
    Ji, Qiuhe
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (06) : 669 - 678
  • [46] UPDATE ON COMPARATIVE CARDIOVASCULAR SAFETY OF FEBUXOSTAT VERSUS ALLOPURINOL AMONG PATIENTS WITH GOUT
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 385 - 385
  • [47] Liver Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease
    Lee, Jung Sun
    Hong, Seokchan
    Won, Jebum
    Kwon, Oh Chan
    Oh, Ji Sean
    Kim, Yong-Gil
    Lee, Chang Keun
    Yoo, Bin
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [48] Hepatic Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease
    Lee, Jung Sun
    Won, Jebum
    Kwon, Oh Chan
    Lee, Seung Soo
    Oh, Ji Seon
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    Hong, Seokchan
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (05) : 527 - 531
  • [49] COMPARISON OF URATE-LOWERING EFFICACY AND SAFETY OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS
    Singh, Gajendera
    Kumar, Hemant
    Soni, Udit
    Tyagi, Shikhar
    Aggarwal, Kritika
    Verma, Kavita
    Kumar, Sumit
    HETEROCYCLIC LETTERS, 2016, 6 (01): : 133 - 147
  • [50] Sex difference in heart failure risk associated with febuxostat and allopurinol in gout patients
    Cheng, Ching-Lan
    Yen, Chi-Tai
    Su, Chien-Chou
    Lee, Cheng-Han
    Huang, Chien-Huei
    Yang, Yea-Huei Kao
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345